PUBLISHER: IMARC | PRODUCT CODE: 1540841
PUBLISHER: IMARC | PRODUCT CODE: 1540841
Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032
The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 114.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.
Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.
The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type, route of administration and distribution channel.
Breakup by Indication:
Multiple Sclerosis
Parkinson's Disease
Alzheimer's Disease
Spinal Muscular Atrophy (SMA)
Huntington's Disease
Others
Breakup by Drug Type:
N-methyl-D-aspartate Receptor Antagonists
Selective Serotonin Reuptake Inhibitors
Dopamine Inhibitors
Breakup by Route of Administration:
Breakup by Distribution Channel:
Breakup by Region:
Competitive Landscape:
Key Questions Answered in This Report:
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
3 Executive Summary
4 Introduction
5 Global Neurodegenerative Disease Treatment Market
6 Market Breakup by Indication
7 Market Breakup by Drug Type
8 Market Breakup by Route of Administration
9 Market Breakup by Distribution Channel
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
List of Figures
- Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2023
- Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2023
- Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
- Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2023
- Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
